TY - JOUR
T1 - Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality
T2 - an international comparative study of 1·95 million events in 80·4 million people in four countries
AU - Camacho, Ximena
AU - Nedkoff, Lee
AU - Wright, F. Lucy
AU - Nghiem, Nhung
AU - Buajitti, Emmalin
AU - Goldacre, Raphael
AU - Rosella, Laura C.
AU - Seminog, Olena
AU - Tan, Eng Joo
AU - Hayes, Alison
AU - Hayen, Andrew
AU - Wilson, Nick
AU - Blakely, Tony
AU - Clarke, Philip
N1 - Funding Information:
PC, FLW, and XC conceptualised the study. XC was responsible for project administration and coordination of all analytical work. AnH, AlH, PC, NW, TB, NN, and LCR were responsible for funding acquisition. XC, LN, FLW, NN, NW, OS, EB, TB, LCR, and PC contributed to development of the study analysis plan. XC, EB, NN, and RG led the data and statistical analyses. RG, EB, NN, and XC had full access to the data in their relevant jurisdictions. All authors reviewed methods and interpreted results. LN, XC, FLW, and PC coordinated manuscript production. LN and XC drafted the manuscript and all authors reviewed and edited the final version of the manuscript. XC, LN, FLW, and PC were responsible for the decision to submit the manuscript for publication.
Funding Information:
NSW, Australia: we acknowledge the NSW Ministry of Health for the provision of data for this study. The Cause of Death Unit Record File is provided by the Australian Coordinating Registry on behalf of Australian Registries of Births, Deaths and Marriages, NSW Coroner and the National Coronial Information System. The Centre for Health Record Linkage is acknowledged for their role in data linkage. LN was supported by a National Health and Medical Research Council of Australia (NHMRC) Early Career Fellowship and a National Heart Foundation Future Leader Fellowship. The research was supported by NHMRC project grant (1084347) and Centre of Excellence in Population Ageing Research, Australian Research Council (CE170100005). Ontario, Canada: this study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and the Ministry of Long-Term Care. This study also received funding from a Canadian Institutes for Health Research operating grant (FRN-142498). LCR is supported by a Canada Research Chair in Population Health Analytics. New Zealand: data is supplied by Statistics New Zealand. The results in this report are not official statistics. They have been created for research purposes from the Integrated Data Infrastructure, managed by Statistics New Zealand. Access to the anonymised data used in this study was provided by Statistics New Zealand under the security and confidentiality provision of the Statistics Act 1975. NN, TB, and NW were supported by the Health Research Council of NZ (grant 16/443). England, UK: data were provided by NHS Digital and held securely in coded form within the Nuffield Department of Population Health at the University of Oxford. The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (NIHR-BRC-1215?20008), and by the Office for Health Improvement and Disparities, and Health Data Research UK (OXFD1). The Big Data Institute has received funding from the Li Ka Shing Foundation and Robertson Foundations, the Medical Research Council, British Heart Foundation, and is supported by the NIHR Oxford Biomedical Research Centre. We thank Nick Hall for his assistance in curating the English datasets used in this study. The analyses, conclusions, opinions, and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred.
Publisher Copyright:
© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license
PY - 2022/3
Y1 - 2022/3
N2 - Background: Myocardial infarction mortality has declined since the 1970s, but contemporary drivers of this trend remain unexplained. The aim of this study was to compare the contribution of trends in event rates and case fatality to declines in myocardial infarction mortality in four high-income jurisdictions from 2002–15. Methods: Linked hospitalisation and mortality data were obtained from New South Wales (NSW), Australia; Ontario, Canada; New Zealand; and England, UK. People aged between 30 years and 105 years were included in the study. Age-adjusted trends in myocardial infarction event rates and case fatality were estimated from Poisson and binomial regression models, and their relative contribution to trends in myocardial infarction mortality calculated. Findings: 1 947 895 myocardial infarction events from a population of 80·4 million people were identified in people aged 30 years or older. There were significant declines in myocardial infarction mortality, event rates, and case fatality in all jurisdictions. Age-standardised myocardial infarction event rates were highest in New Zealand (men 893/100 000 person-years in 2002, 536/100 000 person-years in 2015; women 482/100 000 person-years in 2002, 271/100 000 person-years in 2015) and lowest in England (men 513/100 000 person-years in 2002, 382/100 000 person-years in 2015; women 238/100 000 person-years in 2002, 173/100 000 person-years in 2015). Annual age-adjusted reductions in event rates ranged from –2·6% (95% CI –3·0 to –2·3) in men in England to –4·3% (–4·4 to –4·1) in women in Ontario. Age-standardised case fatality was highest in England in 2002 (48%), but declined at a greater rate than in the other jurisdictions (men –4·1%/year, 95% CI –4·2 to –4·0%; women –4·4%/year, –4·5 to –4·3%). Declines in myocardial infarction mortality rates ranged from –6·1%/year to –7·6%/year. Event rate declines were the greater contributor to myocardial infarction mortality reductions in Ontario (69·4% for men and women), New Zealand (men 68·4%; women 67·5%), and NSW women (60·1%), whereas reductions in case fatality were the greater contributor in England (60% in men and women) and for NSW men (54%). There were greater contributions from case fatality than event rate reductions in people younger than 55 years in all jurisdictions, with contributions to mortality declines varying by country in those aged 55–74 years. Event rate declines had a greater impact than changes in case fatality in those aged 75 years and older. Interpretation: While the mortality burden of myocardial infarction has continued to fall across these four populations, the relative contribution of trends in myocardial infarction event rates and case fatality to declining mortality varied between jurisdictions, including by age and sex. Understanding the causes of this variation will enable optimisation of prevention and treatment efforts. Funding: National Health and Medical Research Council, Australia; Australian Research Council; Health Research Council of New Zealand; Canadian Institutes of Health Research, Canada; National Institute for Health Research, UK.
AB - Background: Myocardial infarction mortality has declined since the 1970s, but contemporary drivers of this trend remain unexplained. The aim of this study was to compare the contribution of trends in event rates and case fatality to declines in myocardial infarction mortality in four high-income jurisdictions from 2002–15. Methods: Linked hospitalisation and mortality data were obtained from New South Wales (NSW), Australia; Ontario, Canada; New Zealand; and England, UK. People aged between 30 years and 105 years were included in the study. Age-adjusted trends in myocardial infarction event rates and case fatality were estimated from Poisson and binomial regression models, and their relative contribution to trends in myocardial infarction mortality calculated. Findings: 1 947 895 myocardial infarction events from a population of 80·4 million people were identified in people aged 30 years or older. There were significant declines in myocardial infarction mortality, event rates, and case fatality in all jurisdictions. Age-standardised myocardial infarction event rates were highest in New Zealand (men 893/100 000 person-years in 2002, 536/100 000 person-years in 2015; women 482/100 000 person-years in 2002, 271/100 000 person-years in 2015) and lowest in England (men 513/100 000 person-years in 2002, 382/100 000 person-years in 2015; women 238/100 000 person-years in 2002, 173/100 000 person-years in 2015). Annual age-adjusted reductions in event rates ranged from –2·6% (95% CI –3·0 to –2·3) in men in England to –4·3% (–4·4 to –4·1) in women in Ontario. Age-standardised case fatality was highest in England in 2002 (48%), but declined at a greater rate than in the other jurisdictions (men –4·1%/year, 95% CI –4·2 to –4·0%; women –4·4%/year, –4·5 to –4·3%). Declines in myocardial infarction mortality rates ranged from –6·1%/year to –7·6%/year. Event rate declines were the greater contributor to myocardial infarction mortality reductions in Ontario (69·4% for men and women), New Zealand (men 68·4%; women 67·5%), and NSW women (60·1%), whereas reductions in case fatality were the greater contributor in England (60% in men and women) and for NSW men (54%). There were greater contributions from case fatality than event rate reductions in people younger than 55 years in all jurisdictions, with contributions to mortality declines varying by country in those aged 55–74 years. Event rate declines had a greater impact than changes in case fatality in those aged 75 years and older. Interpretation: While the mortality burden of myocardial infarction has continued to fall across these four populations, the relative contribution of trends in myocardial infarction event rates and case fatality to declining mortality varied between jurisdictions, including by age and sex. Understanding the causes of this variation will enable optimisation of prevention and treatment efforts. Funding: National Health and Medical Research Council, Australia; Australian Research Council; Health Research Council of New Zealand; Canadian Institutes of Health Research, Canada; National Institute for Health Research, UK.
UR - http://www.scopus.com/inward/record.url?scp=85125460242&partnerID=8YFLogxK
U2 - 10.1016/S2468-2667(22)00006-8
DO - 10.1016/S2468-2667(22)00006-8
M3 - Article
C2 - 35247353
AN - SCOPUS:85125460242
SN - 2468-2667
VL - 7
SP - e229-e239
JO - The Lancet Public Health
JF - The Lancet Public Health
IS - 3
ER -